Metagenes associated with survival in non-small cell lung cancer

Cancer Informatics

Volumn 10, Issue , 2011, Pages 175-183

  Urgard, Egon ^a   Vooder, Tõnu ^a   Võsa, Urmo ^a   Välk, Kristjan ^a   Liu, Mingming ^b   Luo, Cheng ^a   Hoti, Fabian ^c   Roosipuu, Retlav ^d   Annilo, Tarmo ^a   Laine, Jukka ^e   Frenz, Christopher M ^f   Zhang, Liqing ^b   Metspalu, Andres ^a,g  

^a UNIVERSITY OF TARTU   (Estonia)

^b Virginia Polytechnic Institute and State University   (United States)

^c AALTO UNIVERSITY   (Finland)

^d TARTU UNIVERSITY HOSPITAL   (Estonia)

^e UNIVERSITY OF TURKU   (Finland)

^f NEW YORK CITY COLLEGE OF TECHNOLOGY   (United States)

^g UNIVERSITY OF TARTU   (Estonia)

Author keywords

Gene expression pattern; Kaplan Meier curve; Metagenes; Microarray; Non small cell lung cancer; TNM stage

Indexed keywords

ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE M PHASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; MITOSIS; ONCOGENE; PREDICTION; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH; UPREGULATION; VALIDATION PROCESS;

EID: 80053596106     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIN.S7135     Document Type: Article

References (36)

1. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. Nov 1 1999;86(9):1867-76.
2. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. Jan 2007; 12(1): 20-37.
3. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook, 6th New York: Springer-Berlag; 2002:89-98.
4. Rami-Porta R, Chansky K, Goldstraw P. Updated lung cancer staging system. Future Oncol. Dec 2009;5(10):1545-53.
5. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. Aug 2007;2(8):706-14.
6. Boutros PC, Lau SK, Pintilie M, et al. Prognostic gene signatures for non-smallcell lung cancer. Proc Natl Acad Sci U S A. Feb 24 2009;106(8):2824-8.
7. Shedden K, Taylor JM, Enkemann SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med. Aug 2008;14(8):822-7.
8. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. Aug 2002;8(8): 816-24.
9. Raponi M, Zhang Y, Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res. Aug 1 2006;66(15):7466-72.
10. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med. Jan 4 2007;356(1):11-20.
11. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J. Dec 2001;18(6):1059-68.
12. Carr DT, Mountain CF. Staging lung cancer. In: Strauss M, ed. Lung Cancer: Clinical Diagnosis and Treatment New York: Grune and Stratton; 1977: 151-61.
13. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. Jan 1 1995;75(1 Suppl): 191-202.
14. WHO. Histological typing of lung tumours. Tumori. Aug 1981;67(4):253-72.
15. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer staging manual 5th Philadelphia: Lippincott-Raven; 1997.
16. Valk K, Vooder T, Kolde R, et al. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology.79(3-4): 283-92.
17. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit SR, Irizarry WH, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer; 2005:397-420.
18. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 2007;8(1):R3.
19. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. Jul 1 2009;37 (Web Server issue): W317-22.
20. Pittman J, Huang E, Dressman H, et al. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A. Jun 1 2004;101(22):8431-6.
21. Quackenbush J. Computational analysis of cDNA microarray data. Nature Reviews. 2001;6(2):418-28.
22. Albert JH, Chib S. Bayesian analysis of binary and polychotomous response data. Journal of the American Statistical Association. 1993;88(422):669-79.
23. Hoti F, Sillanpaa MJ. Bayesian mapping of genotype x expression interactions in quantitative and qualitative traits. Heredity. Jul 2006;97(1):4-18.
24. Bae K, Mallick BK. Gene selection using a two-level hierarchical Bayesian model. Bioinformatics. Dec 12 2004;20(18):3423-30.
25. Kuner R, Muley T, Meister M, et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer. Jan 2009;63(1):32-8.
26. Saviozzi S, Cordero F, Lo Iacono M, Novello S, Scagliotti GV, Calogero RA. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer. 2006; 6:200.
27. Wu M, Orta L, Gil J, Li G, Hu A, Burstein DE. Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma. Mod Pathol. May 2008;21(5):553-8.
28. Kettunen E, Anttila S, Seppanen JK, et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer- related genes in squamous cell lung cancer. Cancer Genet Cytogenet. Mar 2004;149(2): 98-106.
29. De Martino I, Visone R, Wierinckx A, et al. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. Mar 1 2009;69(5):1844-50.
30. Rohrbeck A, Neukirchen J, Rosskopf M, et al. Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med. 2008;6:69.
31. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med. Mar 2007;13(3):361-6.
32. Franklin WA. RAGE in lung tumors. Am J Respir Crit Care Med. Jan 15 2007;175(2):106-7.
33. Lin J, Lin L, Thomas DG, et al. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants. Clin Cancer Res. Sep 1 2004;10(17):5708-16.
34. Pan JH, Han JX, Wu JM, Sheng LJ, Huang HN. CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer. Acta Oncol. 2007;46(3):361-6.
35. Kolesar JM, Breunig A, Miller J, et al. CYP3A5*3 and CYP3A4*1B polymorphisms are associated and more frequent in NSCLC tumors than in normal volunteers. Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings July 15, 2004;22(14S):2016.
36. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med. Aug 10 2006;355(6):570-80.